1,015 results on '"Fabbri, Leonardo M."'
Search Results
2. Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled study
3. COPD and multimorbidity: recognising and addressing a syndemic occurrence
4. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study
5. Leveraging CT Imaging to Detect COPD and Concomitant Chronic Diseases
6. The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study
7. Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations
8. Urgent need of novel biomarkers of acute dyspnea
9. Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseases
10. Inhaled long-acting muscarinic antagonists in asthma – A narrative review
11. Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases.
12. Prevalence and risk factors for pulmonary embolism in patients with suspected acute exacerbation of COPD: a multi-center study.
13. Electrocardiographic features of patients with COVID-19 pneumonia
14. Chronic cough in adults
15. Multimorbidity in COPD, does sleep matter?
16. Risk and Prevention of Cardiovascular Events After Exacerbations of Respiratory Symptoms
17. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study
18. Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study
19. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial
20. Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
21. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
22. Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD
23. Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS.
24. Cardiac disease
25. Asthma
26. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial
27. Insights, attitudes, and perceptions about asthma and its treatment: a multinational survey of patients from Europe and Canada
28. Differential Diagnosis of Suspected COPD Exacerbations in the Acute Care Setting: Best Practice
29. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study
30. Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States
31. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial
32. Development of a tool to detect small airways dysfunction in asthma clinical practice
33. The Multiple Components of COPD
34. Asthma in the elderly: what we know and what we have yet to know
35. Inhaled corticosteroids in severe COPD patients with cardiovascular diseases. Authors’ reply
36. We Have to Learn to Do without Knowing Enough: Antieosinophilic Treatments for Severe Asthma
37. Baseline Symptom Score Impact on Benefits of Glycopyrrolate/Formoterol Metered Dose Inhaler in COPD
38. Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure
39. The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study
40. Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patients
41. Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone [Corrigendum]
42. Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone
43. Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease
44. Update in Asthma 2016
45. Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD
46. Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice.
47. Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone [Corrigendum]
48. Heart Failure and Chronic Obstructive Pulmonary Disease: The Quandary of Beta-Blockers and Beta-Agonists
49. Invecchiamento, infiammazione sistemica e malattie croniche complesse
50. An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.